Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens
World Health Organization. (2016). Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens. World Health Organization. http://www.who.int/iris/handle/10665/250044
Gov't Doc #WHO/HTM/TB/2016.16
MetadataShow full item record
Showing items related by title and MeSH subject.
Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis Tabarsi, P.; Baghaei, P.; Hemmati, N.; Mirsaeidi, M.; Kazempour, M.; Mansouri, D.; Masjedi, M.R. (2009)We compared the effectiveness of 2 treatment regimens for isoniazid-resistant tuberculosis [TB] in 42 patients attending a TB referral centre in the Islamic Republic of Iran. The patients were divided into 2 treatment groups: 26 received the 6-month standard HRZE treatment and 16 received a modified treatment of RZE for 6 months. There were no significant differences in age or sex of the groups. With the standard method of treatment, 21 [80.8%] patients were cured, 4 [15.4%] resulted in treatment failure, and 1 [3.8%] died. In the modified treatment ...